Search

everythinglearnresearchcommunity

for

Search:↓

Social isolation changes brain receptors and makes ethanol more impactful.

Brain-made chemicals can control nerve cell function differently in various parts of a mouse's brain, which may help us understand neurological conditions.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

2-DG reduces seizures by enhancing brain inhibition through specific receptor activation.

Pregnancy increases certain GABA_A receptors in rat brains, influenced by steroid levels.

During late pregnancy in rats, hormonal changes increased certain GABAA receptors in specific brain cells.

Beetroot extract may help treat hair loss naturally with fewer side effects.

Juniperus plants contain compounds with potential for developing various medical treatments.

New oral treatment, finasteride, effectively and safely treats common hair loss.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Certain medications can cause serious side effects, including skin reactions, stroke, muscle disorders, tongue swelling, hair loss in women, and liver failure.

Antidepressants called SSRIs can cause skin problems, bleeding risk, and other side effects.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Promising treatments for EBS include anti-inflammatory drugs, antibiotics, creams, mTOR inhibitors, and gene editing, but more trials are needed.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

Targeting multiple pathways may improve treatments for androgenetic alopecia.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Topoisomerase inhibitors can cause hair loss, skin rash, hand-foot syndrome, and nail changes.